4.7 Article

Experimental Rhinovirus Infection as a Human Model of Chronic Obstructive Pulmonary Disease Exacerbation

出版社

AMER THORACIC SOC
DOI: 10.1164/rccm.201006-0833OC

关键词

disease exacerbation; respiratory tract infections; COPD; rhinovirus

资金

  1. GlaxoSmithKline
  2. Medical Research Council
  3. British Medical Association
  4. British Lung Foundation/Severin Wunderman Family Foundation [P00/2]
  5. Wellcome Trust [083567/Z/07/Z]
  6. Imperial College
  7. National Institute for Health Research Biomedical Research Centre funding scheme
  8. Pfizer UK
  9. European Respiratory Society fellowship
  10. Chiesi Farmaceutici
  11. Boehringer Ingelheim
  12. Merck Sharp Ex Dohme
  13. AstraZeneca
  14. FAMRI
  15. Centocor
  16. Sanofi-Pasteur
  17. Synairgen
  18. Merck Sharp Dohme
  19. Novartis, Italy
  20. Pfizer
  21. Wellcome Trust [083567/Z/07/Z] Funding Source: Wellcome Trust
  22. Medical Research Council [G1000758, G1000758B] Funding Source: researchfish
  23. National Institute for Health Research [CL-2008-21-014] Funding Source: researchfish

向作者/读者索取更多资源

Rationale: Respiratory virus infections are associated with chronic obstructive pulmonary disease (COPD) exacerbations, but a causative relationship has not been proven. Studies of naturally occurring exacerbations are difficult and the mechanisms linking virus infection to exacerbations are poorly understood. We hypothesized that experimental rhinovirus infection in subjects with COPD would reproduce the features of naturally occurring COPD exacerbations and is a valid model of COPD exacerbations. Objectives: To evaluate experimental rhinovirus infection as a model of COPD exacerbation and to investigate the mechanisms of virus-induced exacerbations. Methods: We used experimental rhinovirus infection in 13 subjects with COPD and 13 nonobstructed control subjects to investigate clinical, physiologic, pathologic, and antiviral responses and relationships between virus load and these outcomes. Measurements and Main Results: Clinical data; inflammatory mediators in blood, sputum, and bronchoalveolar lavage; and viral load in nasal lavage, sputum, and bronchoalveolar lavage were measured at baseline and after infection with rhinovirus 16. After rhinovirus infection subjects with COPD developed lower respiratory symptoms, airflow obstruction, and systemic and airway inflammation that were greater and more prolonged compared with the control group. Neutrophil markers in sputum related to clinical outcomes and virus load correlated with inflammatory markers. Virus load was higher and IFN production by bronchoalveolar lavage cells was impaired in the subjects with COPD. Conclusions: We have developed a new model of COPD exacerbation that strongly supports a causal relationship between rhinovirus infection and COPD exacerbations. Impaired IFN production and neutrophilic inflammation may be important mechanisms in virus-induced COPD exacerbations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据